Lenalidomide improves survival in previously treated patients with multiple myeloma

被引:0
|
作者
不详
机构
来源
ONCOLOGY-NEW YORK | 2006年 / 20卷 / 01期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:43 / 43
页数:1
相关论文
共 50 条
  • [21] Diarrhea Incidence in Multiple Myeloma Patients Treated With Lenalidomide and Pomalidomide
    Montefusco, Vittorio
    Capecchi, Marco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E46 - E46
  • [22] Selinexor for the treatment of patients with previously treated multiple myeloma
    Mo, Clifton C.
    Jagannath, Sundar
    Chari, Ajai
    Nooka, Ajay K.
    Lonial, Sagar
    Siegel, David
    Biran, Noa
    Gasparetto, Cristina
    Bahlis, Nizar J.
    Richardson, Paul
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (08) : 697 - 706
  • [23] DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE
    Capecchi, M.
    Corradini, P.
    Montefusco, V.
    HAEMATOLOGICA, 2016, 101 : 795 - 796
  • [24] Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review
    Al-Ani, Fatimah
    Louzada, Martha L.
    Bastida Bermejo, Jose Maria
    Victoria Mateos, Maria
    BLOOD, 2015, 126 (23)
  • [25] Use of Daratumumab in Patients With Previously Treated Multiple Myeloma
    Patel, Ashwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (14)
  • [26] Survival Effect of Venous Thromboembolism in Patients With Multiple Myeloma Treated With Lenalidomide and High-Dose Dexamethasone
    Zangari, Maurizio
    Tricot, Guido
    Polavaram, Latha
    Zhan, Fenghuang
    Finlayson, Ashlie
    Knight, Robert
    Fu, Tommy
    Weber, Donna
    Dimopoulos, Meletios A.
    Niesvizky, Ruben
    Fink, Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 132 - 135
  • [27] Selinexor, Daratumumab and Dexamethasone for Patients with Multiple Myeloma Previously Treated with Lenalidomide at First Relapse: A Real-World Study
    Zhai, Yingying
    Yan, Lingzhi
    Jin, Song
    Shang, Jingjing
    Shi, Xiaolan
    Yao, Weiqin
    Yan, Zhi
    Yan, Shuang
    Wu, De-pei
    Fu, Chengcheng
    BLOOD, 2023, 142
  • [28] Lenalidomide data in multiple myeloma patients demonstrate impressive survival benefit
    不详
    ONCOLOGY-NEW YORK, 2007, 21 (09): : 1143 - 1143
  • [29] A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
    Huang, Shang-Yi
    Yu, Yuan-Bin
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Wang, Ming-Chung
    Lin, Hsuan-Yu
    Lin, Sheng-Fung
    Lin, Tseng-Hsi
    Hua, Ye
    Puccio-Pick, Marie
    DeMarco, Dena
    Jacques, Christian
    Dunn, Po
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (09) : 705 - 710
  • [30] Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX): A Randomized, Open-Label, Phase III Trial
    Dimopoulos, Meletios A.
    Oriol, Albert
    Nahi, Hareth
    San-Miguel, Jesus
    Bahlis, Nizar J.
    Usmani, Saad Z.
    Rabin, Neil
    Orlowski, Robert Z.
    Suzuki, Kenshi
    Plesner, Torben
    Yoon, Sung-Soo
    Ben Yehuda, Dina
    Richardson, Paul G.
    Goldschmidt, Hartmut
    Reece, Donna
    Ahmadi, Tahamtan
    Qin, Xiang
    Mayo, Wendy Garvin
    Gai, Xue
    Carey, Jodi
    Carson, Robin
    Moreau, Philippe
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (08) : 1590 - +